Trial Profile
Clinical Phase II Study on the first-line chemotherapy for B stage Non-squmaous cell lung cancer, comparing Pemetrexed/Carboplatin with Gemcitabine/Carboplatin.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 May 2012
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Pemetrexed (Primary) ; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 21 May 2012 Planned number of patients changed from 80 to 40 as reported by Chinese Clinical Trial Register record.
- 02 Jan 2012 Planned number of patients changed from 40 to 80 as reported by Chinese Clinical Trial Register.
- 02 Jan 2012 Status changed from not yet recruiting to recruiting as reported by Chinese Clinical Trial Register.